Drug Discovery

Absci Harnesses AI to Transform Drug Discovery in Biotech
Research & Development Absci Harnesses AI to Transform Drug Discovery in Biotech

In a world where the race to develop life-changing therapies is accelerating at an unprecedented pace, biotech innovators are turning to artificial intelligence to redefine the boundaries of drug discovery, and Absci Corporation, a Seattle-based company listed on NASDAQ under the ticker ABSI,

Vaccine Safety Insights: US and Australia COVID-19 Focus
Research & Development Vaccine Safety Insights: US and Australia COVID-19 Focus

In a world still grappling with the aftermath of a global health crisis that recorded over 700 million cases and 7 million deaths, the role of COVID-19 vaccines stands as a testament to human ingenuity and scientific progress. These vaccines, developed at an unprecedented pace through years of

How Is Alnylam Advancing Precision Medicine with Genomic Data?
Research & Development How Is Alnylam Advancing Precision Medicine with Genomic Data?

Imagine a world where treatments for complex diseases are tailored to an individual’s unique genetic makeup, offering hope to patients who have long been out of options, and Alnylam Pharmaceuticals, a pioneer in RNA interference (RNAi) therapeutics, is turning this vision into reality by joining

Optibrium Transforms Drug Discovery with AI and 3D Modeling
Tech & Innovation Optibrium Transforms Drug Discovery with AI and 3D Modeling

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, combined with a deep understanding of technology and innovation, has positioned him as a leading voice in the industry. Today, we'll dive into the transformative role of

Can a Guava-Derived Molecule Revolutionize Liver Cancer Care?
Research & Development Can a Guava-Derived Molecule Revolutionize Liver Cancer Care?

Today, we’re diving into the fascinating world of natural products and their potential in cancer treatment with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development. With a keen focus on innovation and technology in the industry, Ivan has been at the

Mayo Clinic's AI Revolutionizes Heart Failure Drug Discovery
Research & Development Mayo Clinic's AI Revolutionizes Heart Failure Drug Discovery

In a landscape where heart failure impacts over 6 million Americans and stands as a primary driver of hospitalizations and mortality, the urgency for innovative treatment solutions has never been greater, especially when traditional drug development often stretches over a decade and costs upwards

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later